The Only Company in America Making This Nuclear Fuel Is Going Public.

First — what is TRISO, and why does it matter?

TRISO stands for tri-structural isotropic particle fuel: tiny uranium kernels wrapped in layers of carbon and ceramic, each one its own miniature containment vessel. The layers hold in the radioactive byproducts even at extreme temperatures — which is why it's the fuel of choice for the small, advanced reactors (microreactors and high-temperature designs) that companies and the military want to deploy this decade.

Here's the catch the whole sector runs into: you can design a brilliant reactor, but if nobody can make the fuel at scale, it stays on paper. Standard Nuclear is going public precisely because it says it has solved the harder half of that problem — and has a commercial shipment to prove it.

Bellipo is the first platform built entirely around the IPO lifecycle — from S-1 filing to first trade, lockup expiration, and beyond. We deliver real-time pipeline tracking, AI-powered S-1 briefs, and proprietary demand scoring, plus precision alerts: PING fires when pricing becomes official — typically the evening before trading, occasionally the morning of, always before the open — carrying the final offer price. STRIKE fires the instant the first trade prints. Retail investors get to prepare for IPO day with the same intelligence institutions take for granted.

Every figure cited to the company's S-1/A registration statement.

Tiny revenue, enormous order book

Don't let the top line fool you either way. FY2025 revenue was just $3.1 million — a rounding error for a company that will list near a $356M raise. But that's not the number that matters here. The order book is.

Contract backlog runs up to $245 million, with a stated pipeline near $986 million, some of it flowing through a joint venture with the nuclear giant Framatome. And the company sits on roughly $125 million of cash. That combination — real orders, real cash — is why the auditors did something you rarely see for a company this early.

Three lines most readers will skate past

The pitch writes itself. The fine print is where the deal actually lives. These three lines tell you more than the headline ever will.

Pre-revenue nuclear names almost always carry an auditor's “going-concern doubt.” Standard Nuclear's was ALLEVIATED — a clean opinion. That single line is rare at this stage.

Founder Thomas Hendrix controls ~59.5% of the vote through Class B stock that carries 20 votes each. You buy the economics; he keeps the keys. STDN lists as a “controlled company.”

A DoD Strategic Capabilities Office program (~$300M, with a ~$37M award as part), the DOE reactor pilot, and Air Force microreactor pairings. A tailwind — and a concentration risk in one paragraph.

None of it is hidden — it's all in the S-1/A. And none of it makes Standard Nuclear a bad company. It makes it a specific kind of company: a credible, revenue-generating entrant in the hottest energy category on the tape, wrapped in a control structure and a controls issue you should weigh with clear eyes.

Real business, real caveats — priced side by side

Standard Nuclear is the rare pre-mega-cap nuclear name that isn't purely a bet on a lab. It's the only US company with industrial-scale TRISO manufacturing to date, it made its first commercial delivery in June 2026, and its order book and cash give it a materially stronger footing than most deals at this stage.

But weigh it as what it is. The founder controls the vote outright through 20-vote shares, so public holders buy economics without control. The company discloses a material weakness in its internal financial controls, with a brand-new auditor. And its biggest tailwind — deep ties to the DoD and DOE — is also a concentration: government programs move on politics and budgets, not just execution. The full dossier walks every one of these to the exact line in the filing.